Acquisition of Kinapse by HG Capital

Deal typeM&A
IndustryLife Sciences

Kinapse, founded in 2005, provides advisory and operational services to the world’s leading life sciences organisations across a range of specialist areas, including quality and compliance, regulatory and medical affairs, pharmacovigilance and clinical trial disclosure. The Group has offices in the UK, India and the United States and employs over 500 professionals worldwide.

“This investment is recognition of the success already achieved by Kinapse and provides us with a significant financial partner to support our continuing growth as we work with leading pharmaceutical companies to help them rapidly bring new medicines to patients.  We are delighted that our unique model combining advisory and operational services has again been recognised as the best way to support the life sciences industry."

Nicholas Edwards, Chairman, Kinapse

"BDO’s network in the life sciences technology and services space is second to none and proved to be of pivotal importance to understand and meet the Kinapse ecosystem." 

Joris Van Gool, Investment Professional, HgCapital